why choose us

First received: March 31, 2023

Clinical Trial: Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

Study Status: Completed

Recruit Status: RECRUITING

Condition: OSA

Study Type: INTERVENTIONAL


Official Title: Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of Aroxybutynin/Atomoxetine (AD109) to Placebo in Obstructive Sleep Apnea (LunAIRo

Brief Summary: This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.

Read more